SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ImmunityBio converts from Immunomedics
An SI Board Since February 2023
Posts SubjectMarks Bans Symbol
1230 47 0 IBRX
Emcee:  TinfoilHat Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
841Not really a threat (see below for clarity on logic), in my experience oncologisTinfoilHat4January 21
840How does JNJ's bladder cancer drug progress not threaten IBRX? innovativempublicsceenname-January 21
839This may be the first usage of “silly” in this manner on the IMMU board: MessagOlecranon4January 18
838Please keep SAVA comments to the other boards. Bad Karma. Assuming you must owngalt1January 17
837Point taken. Here's another (very old) quote about Wall Street...."Belimannamal1January 17
836---------- If I remember correctly it's..."the number's could get serickerickson-January 17
835I've got to say the JPM presentation was certainly audacious. Thinking of thmannamal1January 17
834Another humdinger of a post from huggenberg. All I can say is wow! $IBRX ReveRedman12342January 16
833Don’t forget ASCO GI is next week. What tidbits on Colon and Prostate trials migRedman1234-January 16
832Great find. Keep in mind Pharma companies always insert a pre-specified early loTinfoilHat8January 16
831From huggenberg ST board. I also as mentioned before expect UK approval with eiRedman12344January 16
830CULVER CITY, Calif.--(BUSINESS WIRE)--Jan. 15, 2025-- ImmunityBio, Inc. ( NASDAQzagnut15January 15
829CULVER CITY, Calif.--(BUSINESS WIRE)--Jan. 15, 2025--ImmunityBio, Inc. (NASDAQ: zagnut14January 15
828I shouldn’t think so? Seems like the need for a P3. While the complete response Redman12341January 15
827Is this likely to have a negative impact on IBRX? FDA Considers TAR-200 in BCG-UCCS6481January 15
826My sense of what belongs is IBRX. You can banter words around with innuendos lefRedman12342January 15
825Sorry if that post offends your sense of what belongs on this board. I was reallEnd2War-January 15
824I just heard an update on TV that the estimated damage loss from the LA fires noEnd2War-January 15
823Can folks try to retrain from all the political views, and what this or that perRedman12346January 15
822Thank you for sharing your story, which is horrifying and only could be told by End2War1January 15
821I would go much further to say what a POS interview. PSS all but genuflected to dorightbythem5January 15
820Damned hard to type with my hands all bloodied and bandaged from trying to catchjargonweary3January 14
819Hope someone can post high level nuggets from the PSS podcast, don't see mysTinfoilHat2January 14
818Not sure how much more I can keep accumulating .... I am almost at IMMU levels aluckydog88-January 14
817I appreciate your taking the time to render such a comprehensive response. ThankFitzhughlaw4January 13
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News